KALA earnings call for the period ending March 31, 2020.
News & Analysis: Kala Pharmaceuticals, Inc.
The growing eye industry is something investors can’t ignore.
How important is it for drugmakers to get their new innovations reimbursed by Medicare? Turns out, it can be life or death for their stocks.
The company finally has a drug product on the market, but it didn't live up to Wall Street's expectations in the second quarter.
KALA earnings call for the period ending June 30, 2019.
KALA earnings call for the period ending March 31, 2019.
The pharma company announced the pricing of a share offering.
KALA earnings call for the period ending December 31, 2017.
The tiny pharma stock's future is cloudier than ever.